ARC-One Solutions Company Profile

Background

Overview

ARC-One Solutions, LLC, established in April 2020, is a technology company specializing in the development of Blood Establishment Computer Software (BECS). The company was founded through a partnership between the American Red Cross and OneBlood, two of the largest blood centers in the United States. ARC-One Solutions aims to provide robust, user-friendly software solutions that support safe, efficient, and compliant management of the regulated blood supply chain. Their mission is to enhance the quality and safety of blood products, thereby contributing to life-saving medical treatments.

Mission and Vision

The mission of ARC-One Solutions is to revolutionize blood supply chain management by delivering innovative software solutions that streamline operations and ensure the highest standards of safety and compliance. Their vision is to become a leading provider of BECS, facilitating the efficient processing of blood products across the United States.

Primary Area of Focus

ARC-One Solutions focuses on developing and implementing advanced software platforms for blood establishments, addressing the critical need for efficient and compliant blood supply chain management.

Industry Significance

In the healthcare industry, particularly within blood banking and transfusion services, the role of BECS is pivotal. By providing a next-generation BECS platform, ARC-One Solutions plays a crucial role in enhancing the safety, efficiency, and compliance of blood supply chains, directly impacting patient care and outcomes.

Key Strategic Focus

Core Objectives

Innovation in Software Development: Design and deploy state-of-the-art BECS that address existing system limitations.

Safety and Compliance: Ensure all software solutions adhere to FDA regulations and industry best practices.

Scalability and Efficiency: Develop systems capable of processing large volumes of blood products across multiple states and territories.

Specific Areas of Specialization

Blood Collection Management: Streamlining the process of blood collection to ensure donor and recipient safety.

Manufacturing and Labeling: Facilitating the efficient processing and labeling of blood products.

Distribution Management: Optimizing the logistics of blood product distribution to healthcare facilities.

Regulatory Compliance: Ensuring all processes meet stringent regulatory standards.

Key Technologies Utilized

Web-Based Applications: Utilizing web-based platforms for real-time data access and management.

Data Analytics: Employing data-driven approaches to inform decision-making and improve operational efficiency.

Quality Management Systems: Implementing systems that monitor and ensure product quality throughout the supply chain.

Primary Markets or Conditions Targeted

ARC-One Solutions primarily targets blood establishments across the United States, including blood centers, hospitals, and healthcare facilities that require efficient and compliant blood supply chain management solutions.

Financials and Funding

Funding History

As of October 2025, specific details regarding ARC-One Solutions' funding history, total funds raised, recent funding rounds, and notable investors are not publicly disclosed.

Intended Utilization of Capital

While specific utilization details are not publicly available, it is anticipated that any raised capital would be directed towards:

Product Development: Enhancing and expanding the BECS platform.

Regulatory Compliance: Ensuring all products meet FDA and industry standards.

Market Expansion: Deploying solutions across a broader range of blood establishments.

Pipeline Development

Key Pipeline Candidates

ARC-One Solutions is focused on the development of its next-generation BECS platform, designed to address the limitations of existing systems and improve the efficiency and safety of blood supply chain management.

Stages of Clinical Trials or Product Development

The BECS platform is in the advanced stages of development, with plans for deployment across multiple states and territories.

Target Conditions

The primary focus is on enhancing the management of blood products, ensuring safety, efficiency, and compliance within the blood supply chain.

Relevant Timelines for Anticipated Milestones

Specific timelines for product deployment and milestones are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

ARC-One Solutions has developed the Regulated Software Application (RSA), a web-based application that facilitates blood collection, manufacturing, labeling, and distribution management. The RSA has been FDA 510(k) cleared and serves as the foundation for the company's BECS platform.

Significant Scientific Methods

Data Analytics: Utilizing data-driven approaches to inform decision-making and improve operational efficiency.

Quality Management Systems: Implementing systems that monitor and ensure product quality throughout the supply chain.

Leadership Team

Key Executive Profiles

Jeffrey Abraham: Executive Creative Director. Former Disney Imagineer with experience in designing and developing live-action experiences for Warner Bros. and LIONSGATE. Served as Art Director for the Magic Kingdom at Walt Disney World.

S. V.: Vice President of Technology Operations. Oversees the technological infrastructure and operations within the company.

A. R.: Vice President of Engineering. Leads the engineering team in the development and implementation of software solutions.

S. H.: Vice President of Quality and Regulatory Affairs. Ensures all products meet regulatory standards and maintain high-quality benchmarks.

B. K.: Vice President of IT Security and Infrastructure. Manages the company's IT security protocols and infrastructure.

J. A.: Executive Creative Director. Leads creative direction and design initiatives within the company.

S. K.: Director of Delivery. Oversees the delivery and implementation of software solutions to clients.

A. H. M.: Director of Compliance and Audits. Manages compliance and audit processes to ensure adherence to industry standards.

J. R.: Director of Architecture and Technology. Leads the architectural design and technological development of software solutions.

Leadership Changes

Specific details regarding recent significant changes or appointments within the company's leadership are not publicly disclosed.

Competitor Profile

Market Insights and Dynamics

The market for blood supply chain management solutions is evolving, with increasing emphasis on technological innovation to enhance efficiency, safety, and compliance. Companies like ARC-One Solutions are at the forefront of this transformation, addressing the critical need for advanced BECS in the healthcare industry.

Competitor Analysis

While specific competitors are not publicly identified, companies offering similar software solutions for blood supply chain management would be considered competitors. The competitive landscape includes both established firms and emerging startups focusing on healthcare technology and regulatory compliance.

Strategic Collaborations and Partnerships

Significant Collaborations

The partnership between the American Red Cross and OneBlood in founding ARC-One Solutions is a significant collaboration that leverages the expertise and resources of two leading blood centers to develop innovative software solutions for blood supply chain management.

Operational Insights

Strategic Considerations

ARC-One Solutions operates in a competitive and regulated environment, necessitating a strong focus on innovation, compliance, and operational efficiency. The company's strategic collaborations and emphasis on quality management position it to effectively navigate the challenges of the blood supply chain management sector.

Strategic Opportunities and Future Directions

Strategic Roadmap

ARC-One Solutions aims to expand the deployment of its BECS platform across the United States, enhancing the efficiency and safety of blood supply chains nationwide. Future business directions include continuous product development, adherence to evolving regulatory standards, and potential expansion into international markets.